|5Feb 2, 5:00 PM ET

Kelly Paul Edward 5

5 · RELMADA THERAPEUTICS, INC. · Filed Feb 2, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
  • Gift

    Stock Option (right to buy)

    2021-07-0818,000132,000 total
    Exercise: $33.43Exp: 2031-01-07Common Stock (18,000 underlying)
  • Gift

    Stock Option (right to buy)

    2021-07-0819,600130,400 total
    Exercise: $8.80Exp: 2029-07-29Common Stock (19,600 underlying)
  • Gift

    Stock Option (right to buy)

    2021-07-086,40041 total
    Exercise: $13.80Exp: 2025-11-12Common Stock (4,800 underlying)
  • Gift

    Stock Option (right to buy)

    2021-07-0856,00094,000 total
    Exercise: $43.47Exp: 2029-12-19Common Stock (56,000 underlying)
Footnotes (5)
  • [F1]Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust.
  • [F2]The options were granted on November 12, 2015. 25% of the options vested one year from the grant date and the remaining 75% of the options vested in equal quarterly increments of 6.25% of the initial option grant over the following three year period.
  • [F3]The options were granted on July 29, 2019. 6.25% of the options vest each quarter from the date of grant.
  • [F4]The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant.
  • [F5]The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant.

Documents

1 file
  • 5
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT